| Literature DB >> 23193398 |
Olga Papadodima1, Allan Sirsjö, Fragiskos N Kolisis, Aristotelis Chatziioannou.
Abstract
Atherosclerosis is a multifactorial disease involving a lot of genes and proteins recruited throughout its manifestation. The present study aims to exploit bioinformatic tools in order to analyze microarray data of atherosclerotic aortic lesions of ApoE knockout mice, a model widely used in atherosclerosis research. In particular, a dynamic analysis was performed among young and aged animals, resulting in a list of 852 significantly altered genes. Pathway analysis indicated alterations in critical cellular processes related to cell communication and signal transduction, immune response, lipid transport, and metabolism. Cluster analysis partitioned the significantly differentiated genes in three major clusters of similar expression profile. Promoter analysis applied to functional related groups of the same cluster revealed shared putative cis-elements potentially contributing to a common regulatory mechanism. Finally, by reverse engineering the functional relevance of differentially expressed genes with specific cellular pathways, putative genes acting as hubs, were identified, linking functionally disparate cellular processes in the context of traditional molecular description.Entities:
Year: 2012 PMID: 23193398 PMCID: PMC3502768 DOI: 10.1155/2012/453513
Source DB: PubMed Journal: Adv Bioinformatics ISSN: 1687-8027
Figure 1Schematic representation of the proposed workflow. Arrows depict the various analysis steps. The bioinformatic tools and databases used for the implementation of each step are also shown.
Figure 2Volcano plots of the gene list as yielded by ANOVA. Each panel represents filtered and normalized data from each experimental condition (3, 6, and 78 weeks old mice). The horizontal axes depict the fold change ratio between ApoE deficient and wild type mice, for each age in log2 scale, while the vertical axes represent statistical significance by depicting the −log10 (FDR).
GO-analysis. The list of 852 significantly altered genes was submitted to GO analysis elucidating over-represented GO terms. GOT P value represents the hypergeometric test P value score for each GO term. Enrichment represents the ratio of the number of times a GO term occurs in the 852 gene list to the number of times this GO term exists in the list of the Affymetrix 430 2.0 array.
| GO annotation | GOT | Enrichment |
|---|---|---|
| Ion transport | 0.00000000003 | 33/498 |
| Signal transduction | 0.00000000004 | 44/803 |
| Cell differentiation | 0.00000000005 | 36/480 |
| Immune response | 0.00000000005 | 32/250 |
| Metabolic process | 0.00000000007 | 38/542 |
| Cell adhesion | 0.00000000011 | 36/387 |
| Protein amino acid phosphorylation | 0.00000000059 | 32/497 |
| Multicellular organismal development | 0.00000000128 | 41/770 |
| Proteolysis | 0.00000000690 | 25/358 |
| Apoptosis | 0.00000010814 | 24/383 |
| Lipid metabolic process | 0.00000328813 | 15/212 |
| Protein transport | 0.00003352383 | 22/465 |
| G-protein coupled receptor signaling | 0.00028681297 | 19/436 |
| Oxidation reduction | 0.00034119987 | 21/510 |
| Cell cycle | 0.00043684087 | 18/417 |
| Cell division | 0.00050194998 | 12/231 |
Expression of genes under the GO term immune response. Values in the three last columns depict fold changes between ApoE knockout and age-matched wild type mice in log2 scale. The majority of genes at 32 and 78 weeks are upregulated.
| Symbol | Description | 6 weeks | 32 weeks | 78 weeks |
|---|---|---|---|---|
| Ccl6 | Chemokine (C-C motif) ligand 6 | −0.17 | 2.25 | 2.23 |
| Cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 0.29 | 1.56 | 1.43 |
| C1qb | Complement component 1, q subcomponent, beta polypeptide | −0.23 | 2.28 | 2.43 |
| H2-Ab1 | Histocompatibility 2, class II antigen A, beta 1 | −0.25 | 1.94 | 2.77 |
| C1qa | Complement component 1, q subcomponent, a polypeptide | −0.08 | 1.98 | 2.18 |
| Tlr2 | Toll-like receptor 2 | 0.14 | 0.99 | 1.38 |
| Ccl7 | Chemokine (C-C motif) ligand 7 | −0.98 | 1.59 | 4.42 |
| C4b | Complement component 4B (Childo blood group) | 0.23 | 1.2 | 1.74 |
| Cblb | Casitas B-lineage lymphoma b | 0.2 | 0.34 | 1.36 |
| Fcgr2b | Fc receptor, IgG, low affinity IIb | −0.1 | 1.93 | 2.19 |
| Cd300lb | CD300 antigen like family member B | −0.46 | 2.83 | 2.87 |
| Susd2 | Sushi domain containing 2 | 0.22 | −0.08 | −1.07 |
| Ccl8 | Chemokine (C-C motif) ligand 8 | 0.33 | 2.92 | 3.01 |
| Cd14 | CD14 antigen | −0.14 | 1.52 | 2.44 |
| Fcgr1 | Fc receptor, IgG, high affinity I | −0.05 | 1.82 | 2.03 |
| Cadm1 | Cell adhesion molecule 1 | −0.57 | 1.5 | 2.01 |
| C2 | Complement component 2 (within H-2S) | −0.81 | 1.02 | −0.03 |
| Clec7a | C-type lectin domain family 7, member a | 0.15 | 3.52 | 3.86 |
| Procr | Protein C receptor, endothelial | −0.25 | 0.77 | 1.02 |
| C1qc | Complement component 1, q subcomponent, C chain | −0.22 | 2.22 | 2.25 |
| Ccl19 | Chemokine (C-C motif) ligand 19 | −0.71 | 1.07 | 1.64 |
| Enpp3 | Ectonucleotide pyrophosphatase/phosphodiesterase 3 | 0.24 | −0.00 | −1.28 |
| Cx3cl1 | Chemokine (C-X3-C motif) ligand 1 | 0.18 | 1.71 | 1.87 |
| Ccl9 | Chemokine (C-C motif) ligand 9 | −0.46 | 1.74 | 2.19 |
| H2-Eb1 | Histocompatibility 2, class II antigen E beta | 0.19 | 1.62 | 2.17 |
| H2-Aa | Histocompatibility 2, class II antigen A, alpha | 0.95 | 2.39 | 2.34 |
| Cxcl12 | Chemokine (C-X-C motif) ligand 12 | −0.34 | 1.1 | 1.95 |
| Enpp1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.14 | 0.37 | 1.08 |
| Rnf19b | Ring finger protein 19B | −0.29 | 0.73 | 2.58 |
| Prg4 | Proteoglycan 4 | 0.16 | 3.33 | 3.99 |
| Irf8 | Interferon regulatory factor 8 | 0.28 | 1.9 | 2.61 |
| Cxcl1 | Chemokine (C-X-C motif) ligand 1 | −0.46 | 1.77 | 2.66 |
Figure 3Hierarchical clustering of the 1033 statistically significant differentiated probesets. Fold changes between the gene expressions in ApoE knockout as compared to age-matched wild type mice are grouped in three major clusters.
Common TF motif families in the promoters of 36 genes belonging to cluster 2 and to the categories “immune response” and “inflammatory response.” The percentage column depicts the percentage of genes whose promoters have at least one match with the respective motif family. Percentages and P value calculations are based on mouse promoters.
| Family | Description |
| % |
|---|---|---|---|
| V$CTCF | CTCF and BORIS gene family | 0.00000185 | 86 |
| V$MZF1 | Myeloid zinc finger 1 factors | 0.00000878 | 89 |
| V$EGRF | EGR/nerve growth factor induced protein C and related factors | 0.00011981 | 86 |
| V$SRFF | Serum response element binding factor | 0.00012387 | 83 |
| V$PLAG | Pleomorphic adenoma gene | 0.00015650 | 86 |
| V$GREF | Glucocorticoid responsive elements | 0.00016410 | 92 |
| V$KLFS | Krueppel like transcription factors | 0.00024104 | 100 |
| V$GLIF | GLI zinc finger family | 0.00170920 | 81 |
| V$STAT | Signal transducer and activator of transcription | 0.00177177 | 92 |
| V$PAX5 | PAX-2/5/8 binding sites | 0.00246076 | 89 |
| V$E2FF | E2F-myc activator/cell cycle regulator | 0.00400401 | 86 |
| V$XBBF | X-box binding factors | 0.00470139 | 89 |
| V$GATA | GATA binding factors | 0.00499105 | 94 |
| V$PAX6 | PAX-4/PAX-6 paired domain binding sites | 0.00504198 | 89 |
| V$ETSF | Human and murine ETS1 factors | 0.00646776 | 100 |
| V$GCMF | Chorion-specific TFs with a GCM DNA binding domain | 0.00921126 | 83 |
| V$HEAT | Heat shock factors | 0.01639280 | 92 |
| V$RXRF | RXR heterodimer binding sites | 0.01834270 | 97 |
| V$FKHD | Fork head domain factors | 0.02095320 | 94 |
| V$IRFF | Interferon regulatory factors | 0.02221250 | 86 |
| V$HAND | Twist subfamily of class B bHLH transcription factors | 0.03199970 | 94 |
| V$ABDB | Abdominal-B type homeodomain transcription factors | 0.04170260 | 89 |
GOrevenge prioritization. The second column refers to the number of GO terms remaining after Gorevenge pruning, reflecting the centrality of each gene, while the third column refers to the original number of biological process category GO terms of each gene. Values in the three last columns depict fold changes between ApoE knockout and age-matched wild type mice in log2 scale. All presented genes are also differentially expressed. Top 20 genes are shown.
| Gene symbol | Remaining GO terms | Original GO terms | 6 weeks | 32 weeks | 78 weeks |
|---|---|---|---|---|---|
| Wnt5a | 63 | 112 | 0.04 | −0.38 | −1.9 |
| Fgfr2 | 56 | 92 | 0.15 | −0.39 | −1.05 |
| P2rx7 | 38 | 73 | 0.02 | 0.61 | 1.84 |
| Igf1 | 34 | 56 | −0.23 | 0.77 | 1.39 |
| Thbs1 | 30 | 42 | −0.02 | 1.59 | 1.99 |
| Ptgs2 | 30 | 37 | −0.27 | 1.76 | 1.7 |
| Foxf1a | 28 | 34 | 0.09 | −0.63 | −1.41 |
| Psen2 | 25 | 37 | −0.4 | 0.23 | 1.02 |
| Ccnd1 | 24 | 37 | −0.01 | 0.67 | 1.07 |
| Slc11a1 | 24 | 40 | −0.16 | 1.29 | 1.9 |
| Lyn | 24 | 33 | −0.01 | 1.07 | 2.26 |
| Cebpa | 24 | 30 | −0.3 | 0.21 | 1.77 |
| Tlr2 | 21 | 47 | 0.14 | 0.99 | 1.38 |
| Osr1 | 21 | 33 | 0.09 | 0.08 | −1.41 |
| Hexb | 19 | 23 | −0.04 | 0.67 | 1 |
| Col1a1 | 19 | 29 | 0.02 | 0.57 | 1.01 |
| Socs3 | 19 | 27 | 0.58 | 1.59 | 3.19 |
| Adam17 | 18 | 29 | −0.22 | 0.27 | 1.07 |
| Cd44 | 18 | 20 | 0.15 | 1.46 | 1.63 |
| Cln8 | 18 | 26 | 0.37 | 0.85 | 1.71 |
Prioritization of the genes presented in Table 4 by BioGraph exploiting unsupervised methodologies for the identification of causative disease-associated genes.
| Gene symbol | Score |
|---|---|
| PTGS2 | 0.003895 |
| CCND1 | 0.000566 |
| CD44 | 0.000279 |
| COL1A1 | 0.000194 |
| ADAM17 | 0.000168 |
| IGF1 | 0.000116 |
| FGFR2 | 0.000116 |
| THBS1 | 0.000097 |
| LYN | 0.000088 |
| SOCS3 | 0.000087 |
| CEBPA | 0.000054 |
| TLR2 | 0.000048 |
| PSEN2 | 0.000045 |
| P2RX7 | 0.000038 |
| WNT5A | 0.000035 |
| lSLC11A1 | 0.000024 |
| CLN8 | 0.000007 |
| FOXF1 | 0.000006 |
| HEXB | 0.000005 |
| OSR1 | 0.000002 |